实验动物与比较医学 ›› 2017, Vol. 37 ›› Issue (1): 1-5.DOI: 10.3969/j.issn.1674-5817.2017.01.001

• 论著 •    下一篇

FGF21siRNA对STZ诱导的1型糖尿病小鼠心脏功能的影响

陈翠1, 孟哲颖1, 郑元义1, 胡兵1,2, 申锷1,2,3   

  1. 1.上海交通大学附属第六人民医院,上海 200233;
    2.上海超声医学研究所, 上海 200233;
    3.上海交通大学医学院附属同仁医院, 上海 200336
  • 收稿日期:2016-09-06 出版日期:2017-02-25 发布日期:2017-02-25
  • 作者简介:陈翠(1989-),女,临床医学硕士研究生。E-mail:sjtuchencui1989@163.com
  • 基金资助:
    国家自然科学基金面上项目(NO.81270208)

Reduction of Cardiac Function Induced by FGF21siRNA in Type 1 Diabetic Mice

CHEN Cui1, MENG Zhe-ying1, ZHENG Yuan-yi1, Hu Bing1,2, SHEN E1,3   

  1. 1. Shanghai Jiaotong Univesity Affiliated No.6 Hospital, Shanghai 200233, China;
    2. Shanghai Institute of Ultrasound in Medicine, Shanghai 200233, China;
    3. Tong Ren Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200336, China
  • Received:2016-09-06 Online:2017-02-25 Published:2017-02-25

摘要: 目的 探讨成纤维细胞生长因子21(FGF21)siRNA对链脲佐菌素(STZ)诱导的1型糖尿病(T1DM)小鼠心脏功能的影响机制。方法 16只8周龄雄性C57BL/6J小鼠随机分为正常对照组(n=6),FGF21siRNA对照组(n=10), 16只T1DM模型小鼠分为T1DM组(n=6),T1DM+FGF21siRNA组(n=10)。T1DM模型由单次腹腔注射STZ(150 mg/kg)建立。8周后行FGF21siRNA给药。实验到达终点时采用小动物高分辨超声仪测量小鼠心脏功能;光学显微镜下HE染色观察心肌细胞形态, Masson染色观察纤维化程度,利用实时 PCR技术检测心肌组织α-肌球蛋白重链(α-MHC),β-肌球蛋白重链(β-MHC), 心房钠尿肽(ANP)、I型胶原(Col I) 和III型胶原(Col III)及FGF 21 mRNA的表达含量。结果 与正常对照组小鼠相比,T1DM小鼠的心脏功能减低,心肌细胞肥大,胶原纤维增生,伴随小鼠心肌组织 ANP、α-MHC、β-MHC、Col I、Col III mRNA表达增加,T1DM小鼠经FGF 21siRNA处理后上述表现进一步加重。结论 FGF21siRNA能降低1型糖尿病小鼠的心脏功能,其机制可能与心肌肥大和心肌纤维化有关。

关键词: 成纤维细胞生长因子21(FGF 21) siRNA, 1型糖尿病(T1DM), 糖尿病心肌病, 心肌肥大

Abstract: Objective To investigate the effects of Fibroblast growth factor 21 (FGF21) siRNA on cardiac function in type 1 diabetic (T1DM) mice and explore the mechanisms of actions. Methods Sixteen C57BL/6J mice were randomly divided into, control group and FGF21siRNA control group, sixteen T1DM model mice were divided into T1DM group and T1DM + FGF21siRNA group, type 1 diabetes was induced by STZ. Cardiac function was analyzed by echocardiography, morphological changes of cardiomyocytes were observed by HE staining, collagen fiber was observed by Masson staining, the expression of α-myocin heavy chain (α-MHC), β-myocin heavy chain (β-MHC), atrial natriuretic peptide (ANP), type I collagen (Col I) and type III collagen (Col III) of myocardium were detected by Real-time PCR. Results The expression of α-MHC, β-MHC, ANP, Col I and Col III in myocardium of T1DM mice treated with FGF21siRNA were increased compared to those of untreated ones. Cardiac function, cardiomyocyte hypertrophy and collagen fiber proliferation of treated mice were worse than those of untreated ones. Conclusion FGF21siRNA may contribute to cardiac malfunction T1DM mice, which may associate with the development of myocardial hypertrophy, myocardial fibrosis.

Key words: FGF21siRNA, Type 1 diabetic (T1DM), Diabetic cardiomyopathy, Myocardial hypertrophy, Myocardial fibrosis

中图分类号: